Shaping the future
 of animal health

Read more

Our commitments
for tomorrow

Read more

Focusing on animal health,
from the beginning

Virbac offers veterinarians, farmers and pet owners in more than 100 countries a comprehensive and practical range of products and services. With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

Read more


Virbac acquired Sasaeah, a leading animal health player in Japan.

2024/04/02 - Financial public releases

Sasaeah.jpgOn April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.

Read more

Asia: our teams support growth in canine dermatology

2024/03/28 - Products

DAILYDERMA IN ASIA.jpgAs in other parts of the world, around 10%1 of dogs in Asia suffer from atopic dermatitis. Since 2022, our teams have been stepping up their efforts to develop our global DailyDerma program in the region. The goal? To better help Asian veterinarians optimize their dermatology practices and improve the management of skin diseases, especially complex atopic dermatitis. 

Read more

2023 Annual results

2024/03/19 - Financial public releases

●    Revenue up 4.9%, enabling market share gains despite difficulties in 2023

●    2023 operating profitability1 at an all-time high of 23.2% of revenue
     ○ Up 0.4 points compared to 2022 

●    Strong momentum expected in 2024
     ○  Expected revenue growth of 4% to 6% at constant exchange rates and scope
     ○  Operating profitability1 expected to rise by 0,5 point


Read more